PL378065A1 - Substituted n-arylheterocycles, method for production and use thereof as medicaments - Google Patents
Substituted n-arylheterocycles, method for production and use thereof as medicamentsInfo
- Publication number
- PL378065A1 PL378065A1 PL378065A PL37806504A PL378065A1 PL 378065 A1 PL378065 A1 PL 378065A1 PL 378065 A PL378065 A PL 378065A PL 37806504 A PL37806504 A PL 37806504A PL 378065 A1 PL378065 A1 PL 378065A1
- Authority
- PL
- Poland
- Prior art keywords
- arylheterocycles
- medicaments
- substituted
- production
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10306250A DE10306250A1 (en) | 2003-02-14 | 2003-02-14 | Substituted N-aryl heterocycles, processes for their preparation and their use as pharmaceuticals |
Publications (1)
Publication Number | Publication Date |
---|---|
PL378065A1 true PL378065A1 (en) | 2006-02-20 |
Family
ID=32841665
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL378065A PL378065A1 (en) | 2003-02-14 | 2004-02-13 | Substituted n-arylheterocycles, method for production and use thereof as medicaments |
Country Status (29)
Country | Link |
---|---|
EP (1) | EP1597228A2 (en) |
JP (1) | JP2006517563A (en) |
KR (1) | KR20050101215A (en) |
CN (1) | CN100506792C (en) |
AR (1) | AR044496A1 (en) |
AU (1) | AU2004212145B2 (en) |
BR (1) | BRPI0407504A (en) |
CA (1) | CA2516118A1 (en) |
CO (1) | CO5690548A2 (en) |
DE (1) | DE10306250A1 (en) |
EC (1) | ECSP055967A (en) |
HR (1) | HRP20050710A2 (en) |
MA (1) | MA27735A1 (en) |
MX (1) | MXPA05008449A (en) |
MY (1) | MY139102A (en) |
NO (1) | NO20054220L (en) |
NZ (1) | NZ541823A (en) |
OA (1) | OA13027A (en) |
PA (1) | PA8595901A1 (en) |
PE (1) | PE20040952A1 (en) |
PL (1) | PL378065A1 (en) |
RS (1) | RS20050666A (en) |
RU (1) | RU2005128551A (en) |
TN (1) | TNSN05194A1 (en) |
TW (1) | TW200510297A (en) |
UA (1) | UA86760C2 (en) |
UY (1) | UY28186A1 (en) |
WO (1) | WO2004072025A2 (en) |
ZA (1) | ZA200506369B (en) |
Families Citing this family (116)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7351719B2 (en) | 2002-10-31 | 2008-04-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds |
AU2004247626B8 (en) | 2003-05-15 | 2011-05-19 | Arqule, Inc. | Imidazothiazoles and imidazoxazole derivatives as inhibitors of p38 |
EP1867644B1 (en) * | 2003-07-24 | 2009-05-20 | Euro-Celtique S.A. | Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
DK1648879T3 (en) | 2003-07-24 | 2009-02-23 | Euro Celtique Sa | Heteroberl-tetrahydropyridyl compounds useful for treating or preventing pain |
JP4866610B2 (en) * | 2003-08-18 | 2012-02-01 | 富士フイルムファインケミカルズ株式会社 | Pyridyltetrahydropyridines and pyridylpiperidines |
US7592373B2 (en) | 2003-12-23 | 2009-09-22 | Boehringer Ingelheim International Gmbh | Amide compounds with MCH antagonistic activity and medicaments comprising these compounds |
DE10360745A1 (en) * | 2003-12-23 | 2005-07-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | New amide compounds having MCH antagonist activity and medicaments containing these compounds |
DE102004003812A1 (en) * | 2004-01-25 | 2005-08-11 | Aventis Pharma Deutschland Gmbh | Aryl-substituted heterocycles, methods of their preparation and their use as pharmaceuticals |
US7319108B2 (en) | 2004-01-25 | 2008-01-15 | Sanofi-Aventis Deutschland Gmbh | Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
US7829560B2 (en) | 2004-07-08 | 2010-11-09 | Arqule, Inc. | 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase |
WO2006022442A1 (en) * | 2004-08-24 | 2006-03-02 | Santen Pharmaceutical Co., Ltd. | Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
GB0420722D0 (en) | 2004-09-17 | 2004-10-20 | Addex Pharmaceuticals Sa | Novel allosteric modulators |
TW200626138A (en) * | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
AU2005290436A1 (en) * | 2004-10-01 | 2006-04-13 | Banyu Pharmaceutical Co.,Ltd | 2-arylcarboxamide-nitrogeneous heterocycle compound |
DE602005018381D1 (en) | 2004-10-18 | 2010-01-28 | Lilly Co Eli | 1- (HETERO) ARYL-3-AMINOPYRROLIDINE DERIVATIVES FOR USE AS ANTAGONISTS OF THE MGLUR3 RECEPTOR |
CA2584368A1 (en) | 2004-10-19 | 2006-04-27 | Arqule, Inc. | Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase |
DE102004051277A1 (en) * | 2004-10-21 | 2006-04-27 | Merck Patent Gmbh | Heterocyclic carbonyl compounds |
WO2006054793A1 (en) * | 2004-11-19 | 2006-05-26 | The New Industry Research Organization | Benzofuran compound and pharmaceutical composition containing the same |
RS54136B1 (en) | 2004-12-30 | 2015-12-31 | Janssen Pharmaceutica Nv | Piperidine- and piperazine-1-carboxylic acid amide derivatives and related compounds as modulators of fatty acid amide hydrolase (faah) for the treatment of anxiety, pain and other conditions |
WO2006081389A1 (en) | 2005-01-25 | 2006-08-03 | Synta Pharmaceuticals Corp. | Thiophene compounds for inflammation and immune-related uses |
ATE429428T1 (en) | 2005-09-30 | 2009-05-15 | Hoffmann La Roche | INDANDERIVATES AS ANTAGONISTS OF THE MCH RECEPTOR |
EP1987028A2 (en) | 2006-02-10 | 2008-11-05 | Transtech Pharma, Inc. | Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors |
BRPI0707870A2 (en) * | 2006-02-15 | 2011-05-10 | Sanofi Aventis | Amino Alcohol-Substituted Arylthienopyrimidinones, Process for Preparation and Use as Medicines |
AU2007214708A1 (en) * | 2006-02-15 | 2007-08-23 | Sanofi-Aventis | Novel azacycly-substituted arylthienopyrimidinones, process for their preparation and their use as medicaments |
TWI417095B (en) | 2006-03-15 | 2013-12-01 | Janssen Pharmaceuticals Inc | 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors |
EP2009005A4 (en) | 2006-04-19 | 2010-06-02 | Astellas Pharma Inc | Azolecarboxamide derivative |
BRPI0710540B1 (en) | 2006-04-19 | 2022-04-12 | Novartis Ag | 6-o-substituted benzoxazole and benzothiazole compounds, and pharmaceutical composition |
UA93548C2 (en) | 2006-05-05 | 2011-02-25 | Айерем Елелсі | Compounds and compositions as hedgehog pathway modulators |
KR101441365B1 (en) | 2006-05-08 | 2014-09-18 | 어리어드 파마슈티칼스, 인코포레이티드 | Monocyclic heteroaryl compounds |
JP5273037B2 (en) * | 2006-05-08 | 2013-08-28 | アリアド・ファーマシューティカルズ・インコーポレイテッド | Acetylene heteroaryl compounds |
MX2009001043A (en) | 2006-08-08 | 2009-02-06 | Sanofi Aventis | Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use. |
KR20090040478A (en) | 2006-08-24 | 2009-04-24 | 노파르티스 아게 | 2-(pyrazin-2-yl)-thiazole and 2-(1h-pyraz0l-3-yl)-thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
BRPI0716532A2 (en) * | 2006-09-11 | 2013-09-24 | Glaxo Group Ltd | azabicyclic compounds as monoamine resorption inhibitors |
JP2010504362A (en) * | 2006-09-25 | 2010-02-12 | アレテ セラピューティクス, インコーポレイテッド | Soluble epoxide hydrolase inhibitor |
PE20080888A1 (en) * | 2006-10-18 | 2008-08-26 | Novartis Ag | HETEROCYCLIC COMPOUNDS AS ACIL-TRANSFERASE INHIBITORS OF ACIL-CoA-DIACIL-GLYCEROL 1 (DGAT1) |
ES2449482T3 (en) * | 2007-01-09 | 2014-03-19 | Amgen Inc. | Bis-aryl-amide derivatives useful for cancer treatment |
TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
GB0706793D0 (en) * | 2007-04-05 | 2007-05-16 | Evotec Ag | Compounds |
AR066911A1 (en) * | 2007-06-08 | 2009-09-23 | Janssen Pharmaceutica Nv | PIPERIDINE / PIPERAZINE DERIVATIVES |
JO2972B1 (en) | 2007-06-08 | 2016-03-15 | جانسين فارماسوتيكا ان. في | Piperidine/Piperazine derivatives |
EP2152271B1 (en) | 2007-06-08 | 2015-10-21 | Janssen Pharmaceutica, N.V. | Piperidine/piperazine derivatives |
JP5464709B2 (en) | 2007-06-08 | 2014-04-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Piperidine / piperazine derivatives |
TWI452044B (en) | 2007-06-15 | 2014-09-11 | Mitsubishi Tanabe Pharma Corp | Morpholine derivative |
TW200918521A (en) * | 2007-08-31 | 2009-05-01 | Astrazeneca Ab | Heterocyclic amides and methods of use thereof |
ES2409215T3 (en) | 2007-09-14 | 2013-06-25 | Janssen Pharmaceuticals, Inc. | 1-3-disubstituted 4-phenyl-1H-pyridin-2-ones |
SI2203439T1 (en) | 2007-09-14 | 2011-05-31 | Ortho Mcneil Janssen Pharm | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-y1, 4' bipyridinyl-2'-ones |
EA019085B1 (en) | 2007-09-14 | 2014-01-30 | Янссен Фармасьютикалз, Инк. | 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones |
MY148807A (en) * | 2007-10-17 | 2013-05-31 | Sanofi Aventis | Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof |
WO2009052063A1 (en) * | 2007-10-17 | 2009-04-23 | Sanofi-Aventis | Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
RS52235B (en) * | 2007-10-17 | 2012-10-31 | Sanofi | Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
CA2702482C (en) * | 2007-10-17 | 2012-11-27 | Sanofi-Aventis | Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
CN101835764B (en) | 2007-10-24 | 2012-09-19 | 安斯泰来制药有限公司 | Azolecarboxamide compound or salt thereof |
RU2492170C9 (en) | 2007-11-14 | 2013-12-27 | Орто-Макнейл-Янссен Фармасьютикалз, Инк. | Imidazo[1,2-a]pyridine derivatives and their application as positive allosteric modulators of mglur2 receptors |
EP2070924A1 (en) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | New 2 hetarylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
EP2070916A1 (en) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | 2-Arylthiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
EP2070925A1 (en) | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | New 2-substituted tiazol-4-carboxylic acid derivatives, their manufacture and use as medicine |
RU2364597C1 (en) * | 2007-12-14 | 2009-08-20 | Андрей Александрович Иващенко | HETEROCYCLIC INHIBITORS OF Hh-SYGNAL CASCADE, BASED ON THEM MEDICINAL COMPOSITIONS AND METHOD OF TREATING DISEASES INDUCED BY ABBARANT ACTIVITY OF Hh-SIGNAL SYSTEM |
EP2296659B1 (en) | 2008-06-05 | 2016-12-21 | Janssen Pharmaceutica, N.V. | Drug combinations comprising a DGAT inhibitor and a PPAR-agonist |
US8470841B2 (en) | 2008-07-09 | 2013-06-25 | Sanofi | Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof |
BRPI0918055A2 (en) | 2008-09-02 | 2015-12-01 | Addex Pharmaceuticals Sa | 3-azabicyclo [3,1,0] hexyl derivatives as metabotropic glutamate receptor modulators. |
CA2737699A1 (en) * | 2008-09-16 | 2010-03-25 | Merck Sharp & Dohme Corp. | Phthalimide derivative metabotropic glutamate r4 ligands |
JP2012006837A (en) * | 2008-09-30 | 2012-01-12 | Mochida Pharmaceut Co Ltd | 2-indoleacrylamide analogue |
WO2010043396A1 (en) | 2008-10-16 | 2010-04-22 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
WO2010056311A1 (en) | 2008-11-12 | 2010-05-20 | Ariad Pharmaceuticals, Inc. | Pyrazinopyrazines and derivatives as kinase inhibitors |
CN102232074B (en) | 2008-11-28 | 2014-12-03 | 奥梅-杨森制药有限公司 | Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors |
AR074466A1 (en) * | 2008-12-05 | 2011-01-19 | Sanofi Aventis | PIPERIDINE ESPIRO PIRROLIDINONA AND PIPERIDINONA REPLACED AND ITS THERAPEUTIC USE IN DISEASES MEDIATED BY THE MODULATION OF H3 RECEPTORS. |
WO2010068601A1 (en) | 2008-12-08 | 2010-06-17 | Sanofi-Aventis | A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof |
UA103918C2 (en) | 2009-03-02 | 2013-12-10 | Айерем Элелси | N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators |
EP2404902A1 (en) | 2009-03-05 | 2012-01-11 | Shionogi&Co., Ltd. | Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
EP2404896A1 (en) * | 2009-03-05 | 2012-01-11 | Shionogi&Co., Ltd. | Cyclohexane derivative having npy y5 receptor antagonism |
ME01573B (en) | 2009-05-12 | 2014-09-20 | Addex Pharma Sa | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
BRPI1010831A2 (en) | 2009-05-12 | 2016-04-05 | Addex Pharmaceuticals Sa | 1,2,4-triazolo [4,3-a] pyridine derivatives and their as positive allosteric modulators of mglur2 receptors |
MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
ES2443016T3 (en) | 2009-08-26 | 2014-02-17 | Sanofi | New crystalline hydrates of heteroaromatic fluoroglycosides, pharmaceutical products comprising these compounds, and their use |
US20120225097A1 (en) | 2009-11-12 | 2012-09-06 | Hawryluk Natalie A | Piperazinecarboxamide derivative useful as a modulator of fatty acid amide hydrolase (faah) |
US9452980B2 (en) | 2009-12-22 | 2016-09-27 | Hoffmann-La Roche Inc. | Substituted benzamides |
UA108233C2 (en) | 2010-05-03 | 2015-04-10 | Fatty acid amide hydrolysis activity modulators | |
EP2569304A1 (en) * | 2010-05-11 | 2013-03-20 | Sanofi | Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
WO2011143162A1 (en) * | 2010-05-11 | 2011-11-17 | Sanofi | Substituted n-heteroaryl bipyrrolidine carboxamides, preparation and therapeutic use thereof |
AR083718A1 (en) * | 2010-05-11 | 2013-03-20 | Sanofi Aventis | PIRROLIDINE CYCLALQUIL PHENYL (PIPERIDINE) SUBSTITUTED ESPIROLACTAMAS, PREPARATION AND THERAPEUTIC USE OF THE SAME |
UY33469A (en) | 2010-06-29 | 2012-01-31 | Irm Llc Y Novartis Ag | COMPOSITIONS AND METHODS TO MODULATE THE WNT SIGNALING ROAD |
US8993591B2 (en) | 2010-11-08 | 2015-03-31 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a] pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors |
WO2012062751A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
JP5852664B2 (en) | 2010-11-08 | 2016-02-03 | ジヤンセン・フアーマシユーチカルズ・インコーポレーテツド | 1,2,4-Triazolo [4,3-a] pyridine derivatives and their use as positive allosteric modulators of the mGluR2 receptor |
WO2012120054A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8895547B2 (en) | 2011-03-08 | 2014-11-25 | Sanofi | Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
US8710050B2 (en) | 2011-03-08 | 2014-04-29 | Sanofi | Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US8809325B2 (en) | 2011-03-08 | 2014-08-19 | Sanofi | Benzyl-oxathiazine derivatives substituted with adamantane and noradamantane, medicaments containing said compounds and use thereof |
WO2012120050A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Novel substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof |
EP2766349B1 (en) | 2011-03-08 | 2016-06-01 | Sanofi | Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof |
WO2012120058A1 (en) | 2011-03-08 | 2012-09-13 | Sanofi | Oxathiazine derivatives which are substituted with benzyl or heteromethylene groups, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8871758B2 (en) | 2011-03-08 | 2014-10-28 | Sanofi | Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
US9051265B2 (en) | 2011-06-06 | 2015-06-09 | The Scripps Research Institute | N-benzylindole modulators of PPARG |
WO2012170554A1 (en) | 2011-06-06 | 2012-12-13 | Theodore Mark Kamenecka | N-biphenylmethylindole modulators of pparg |
US9309227B2 (en) | 2011-11-22 | 2016-04-12 | The Scripps Research Institute | N-biphenylmethylbenzimidazole modulators of PPARG |
WO2013085954A1 (en) | 2011-12-06 | 2013-06-13 | Janssen Pharmaceutica Nv | Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors |
WO2013085957A1 (en) | 2011-12-06 | 2013-06-13 | Janssen Pharmaceutica Nv | Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors |
MX2014013752A (en) * | 2012-05-11 | 2014-12-08 | Abbvie Inc | Nampt inhibitors. |
CN105101959B (en) | 2012-11-05 | 2018-04-17 | 南特知识产权控股有限责任公司 | The derivative containing cyclic sulfonamide as the inhibitor of hedgehog signal transduction pathway |
TW201444798A (en) | 2013-02-28 | 2014-12-01 | 必治妥美雅史谷比公司 | Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors |
WO2014134391A1 (en) | 2013-02-28 | 2014-09-04 | Bristol-Myers Squibb Company | Phenylpyrazole derivatives as potent rock1 and rock2 inhibitors |
JO3368B1 (en) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
JO3367B1 (en) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
LT3096790T (en) | 2014-01-21 | 2019-10-10 | Janssen Pharmaceutica, N.V. | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
SI3431106T1 (en) | 2014-01-21 | 2021-03-31 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators of metabotropic glutamatergic receptor subtype 2 and their use |
WO2015161108A1 (en) | 2014-04-16 | 2015-10-22 | The Scripps Research Institute | Pparg modulators for treatment of osteoporosis |
JP2017520612A (en) * | 2014-07-16 | 2017-07-27 | ノボジェン リミティッド | Functionalized substituted indoles as anticancer agents |
ES2838573T3 (en) * | 2014-08-21 | 2021-07-02 | Bristol Myers Squibb Co | Benzamide derivatives linked as potent ROCK inhibitors |
WO2016040498A1 (en) * | 2014-09-10 | 2016-03-17 | Epizyme, Inc. | Isoxazole carboxamide compounds |
JP2018526372A (en) * | 2015-08-28 | 2018-09-13 | グレンマーク・ファーマシューティカルズ・エスエー | Novel carbocyclic compounds as ROR gamma modulators |
PE20181446A1 (en) | 2016-03-17 | 2018-09-12 | Hoffmann La Roche | DERIVATIVES OF 5-ETHYL-4-METHYL-PIRAZOL-3-CARBOXAMIDE WITH ACTIVITY AS OF TAAR |
CN108815167B (en) * | 2017-05-24 | 2021-04-13 | 四川晶华生物科技有限公司 | Application of compound in preparing medicine for treating tumor |
TW202136238A (en) * | 2020-01-06 | 2021-10-01 | 大陸商廣東東陽光藥業有限公司 | ROR[gamma]T inhibitor, preparation method therefor and use thereof |
CN115160269A (en) * | 2021-04-02 | 2022-10-11 | 北京大学 | Arylcarboxamide derivatives as positive allosteric modulators of NMDAR |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2663336B1 (en) | 1990-06-18 | 1992-09-04 | Adir | NOVEL PEPTIDE DERIVATIVES, THEIR PREPARATION PROCESS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. |
ES2162941T3 (en) * | 1994-10-26 | 2002-01-16 | Upjohn Co | ANTIMICROBIAL COMPOUNDS OF PHENYLOXAZOLIDINONE. |
CZ220498A3 (en) | 1996-01-17 | 1998-11-11 | Novo Nordisk A/S | Derivatives of 1,2,4-thiadiazine and 1,4-thiazine, process of their preparation and use |
PT944648E (en) | 1996-08-30 | 2007-06-26 | Novo Nordisk As | Glp-1 derivatives |
DE69723869T2 (en) | 1996-12-31 | 2004-04-22 | Dr. Reddy's Laboratories Ltd. | HETEROCYCLIC COMPOUNDS, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEIR AND THEIR APPLICATION IN THE TREATMENT OF DIABETIS AND RELATED DISEASES |
DE19726167B4 (en) | 1997-06-20 | 2008-01-24 | Sanofi-Aventis Deutschland Gmbh | Insulin, process for its preparation and pharmaceutical preparation containing it |
HUP0003999A3 (en) | 1997-07-16 | 2003-03-28 | Novo Nordisk As | Fused 1,2,4-thiadiazine derivatives, their preparation, their use and pharmaceutical compositions containing them |
CO4970713A1 (en) | 1997-09-19 | 2000-11-07 | Sanofi Synthelabo | DERIVATIVES OF CARBOXAMIDOTIAZOLES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM |
JP2001522836A (en) * | 1997-11-07 | 2001-11-20 | シェーリング コーポレイション | Phenyl-alkyl-imidazoles as H3 receptor antagonists |
US6221897B1 (en) | 1998-06-10 | 2001-04-24 | Aventis Pharma Deutschland Gmbh | Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
DE19845405C2 (en) | 1998-10-02 | 2000-07-13 | Aventis Pharma Gmbh | Aryl-substituted propanolamine derivatives and their use |
WO2000035454A1 (en) | 1998-12-18 | 2000-06-22 | Du Pont Pharmaceuticals Company | N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
GB9900416D0 (en) | 1999-01-08 | 1999-02-24 | Alizyme Therapeutics Ltd | Inhibitors |
ATE286026T1 (en) * | 1999-02-10 | 2005-01-15 | Mitsubishi Pharma Corp | AMIDE DERIVATIVES AND THEIR MEDICAL USE |
TR200102911T2 (en) * | 1999-04-09 | 2002-01-21 | Astrazeneca Ab | Adamantane derivatives. |
WO2000063208A1 (en) | 1999-04-16 | 2000-10-26 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
WO2000066585A1 (en) | 1999-04-30 | 2000-11-09 | Neurogen Corporation | 9H-PYRIMIDO[4,5-b]INDOLE DERIVATIVES: CRF1 SPECIFIC LIGANDS |
GB9911863D0 (en) | 1999-05-21 | 1999-07-21 | Knoll Ag | Therapeutic agents |
SE9901875D0 (en) * | 1999-05-25 | 1999-05-25 | Astra Pharma Prod | Novel compounds |
JP2003502369A (en) | 1999-06-18 | 2003-01-21 | メルク エンド カムパニー インコーポレーテッド | Arylthiazolidinedione derivatives and aryloxazolidinedione derivatives |
CA2378878A1 (en) | 1999-07-29 | 2001-02-08 | Jeffrey Thomas Mullaney | Benzofurylpiperazines and benzofurylhomopiperazines: serotonin agonists |
CA2383781A1 (en) | 1999-09-01 | 2001-03-08 | Aventis Pharma Deutschland Gmbh | Sulfonyl carboxamide derivatives, method for their production and their use as medicaments |
CN1430603A (en) | 2000-04-28 | 2003-07-16 | 旭化成株式会社 | Novel bicyclic compounds |
MXPA02010452A (en) | 2000-05-11 | 2003-06-06 | Bristol Myers Squibb Co | Tetrahydroisoquinoline analogs useful as growth hormone secretagogues. |
EP1289526A4 (en) | 2000-05-30 | 2005-03-16 | Merck & Co Inc | Melanocortin receptor agonists |
PL363960A1 (en) * | 2000-07-17 | 2004-11-29 | Ranbaxy Laboratories Limited | Oxazolidinone derivatives as antimicrobials |
US6525202B2 (en) * | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
AP2003002720A0 (en) * | 2000-07-31 | 2003-06-30 | Smithkline Beecham Plc | Carboxamide compounds and their use as antagonists of a human 11 CBY receptor. |
JO2654B1 (en) * | 2000-09-04 | 2012-06-17 | شركة جانسين فارماسوتيكا ان. في | Polyarylcarboxamides useful as lipid lowering agents |
JO2409B1 (en) * | 2000-11-21 | 2007-06-17 | شركة جانسين فارماسوتيكا ان. في | Biphenylcarboxamides useful as lipid lowering agents |
JP2002338537A (en) * | 2001-05-16 | 2002-11-27 | Mitsubishi Pharma Corp | Amide compound and its medicinal use |
WO2002098839A1 (en) * | 2001-06-01 | 2002-12-12 | Tanabe Seiyaku Co., Ltd. | Biphenylcarboxamides and process for preparation thereof |
WO2002098871A1 (en) * | 2001-06-01 | 2002-12-12 | Tanabe Seiyaku Co., Ltd. | Phenylcarboxamides and process for preparation thereof |
AU2002346048A1 (en) * | 2001-06-07 | 2002-12-16 | Merck And Co., Inc. | Benzodiazepine bradykinin antagonists |
DE10142734A1 (en) | 2001-08-31 | 2003-03-27 | Aventis Pharma Gmbh | New (((oxazolylalkyl)-cycloalkyl)-alkyl)-benzoic acid derivatives, are peroxisome proliferator activated receptor agonists or antagonists used e.g. for treating lipid metabolism disorders, type II diabetes, syndrome X and obesity |
BR0309475A (en) * | 2002-04-23 | 2005-03-01 | Shionogi & Co | Pyrazolo [1,5-a] pyrimidine derivatives and nad (p) h oxidase inhibitors containing them |
JP2004175739A (en) * | 2002-11-28 | 2004-06-24 | Tanabe Seiyaku Co Ltd | Medicinal composition |
-
2003
- 2003-02-14 DE DE10306250A patent/DE10306250A1/en not_active Withdrawn
-
2004
- 2004-02-13 NZ NZ541823A patent/NZ541823A/en unknown
- 2004-02-13 PE PE2004000158A patent/PE20040952A1/en not_active Application Discontinuation
- 2004-02-13 WO PCT/EP2004/001342 patent/WO2004072025A2/en active Search and Examination
- 2004-02-13 MX MXPA05008449A patent/MXPA05008449A/en active IP Right Grant
- 2004-02-13 AU AU2004212145A patent/AU2004212145B2/en not_active Ceased
- 2004-02-13 CN CNB2004800098606A patent/CN100506792C/en not_active Expired - Fee Related
- 2004-02-13 RU RU2005128551/04A patent/RU2005128551A/en not_active Application Discontinuation
- 2004-02-13 OA OA1200500227A patent/OA13027A/en unknown
- 2004-02-13 RS YUP-2005/0666A patent/RS20050666A/en unknown
- 2004-02-13 UY UY28186A patent/UY28186A1/en unknown
- 2004-02-13 TW TW093103412A patent/TW200510297A/en unknown
- 2004-02-13 PL PL378065A patent/PL378065A1/en not_active Application Discontinuation
- 2004-02-13 JP JP2006501827A patent/JP2006517563A/en active Pending
- 2004-02-13 EP EP04710808A patent/EP1597228A2/en not_active Withdrawn
- 2004-02-13 KR KR1020057014989A patent/KR20050101215A/en not_active Application Discontinuation
- 2004-02-13 CA CA002516118A patent/CA2516118A1/en not_active Abandoned
- 2004-02-13 MY MYPI20040479A patent/MY139102A/en unknown
- 2004-02-13 UA UAA200508733A patent/UA86760C2/en unknown
- 2004-02-13 BR BRPI0407504-8A patent/BRPI0407504A/en not_active IP Right Cessation
- 2004-02-13 PA PA20048595901A patent/PA8595901A1/en unknown
- 2004-02-16 AR ARP040100469A patent/AR044496A1/en unknown
-
2005
- 2005-08-10 ZA ZA200506369A patent/ZA200506369B/en unknown
- 2005-08-11 CO CO05079788A patent/CO5690548A2/en not_active Application Discontinuation
- 2005-08-11 MA MA28430A patent/MA27735A1/en unknown
- 2005-08-11 EC EC2005005967A patent/ECSP055967A/en unknown
- 2005-08-12 TN TNP2005000194A patent/TNSN05194A1/en unknown
- 2005-08-12 HR HR20050710A patent/HRP20050710A2/en not_active Application Discontinuation
- 2005-09-12 NO NO20054220A patent/NO20054220L/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA05008449A (en) | 2006-05-25 |
WO2004072025A3 (en) | 2004-12-23 |
AU2004212145A1 (en) | 2004-08-26 |
CA2516118A1 (en) | 2004-08-26 |
ZA200506369B (en) | 2006-07-26 |
UA86760C2 (en) | 2009-05-25 |
CN100506792C (en) | 2009-07-01 |
UY28186A1 (en) | 2004-09-30 |
TW200510297A (en) | 2005-03-16 |
MY139102A (en) | 2009-08-28 |
ECSP055967A (en) | 2006-01-16 |
RS20050666A (en) | 2007-12-31 |
CO5690548A2 (en) | 2006-10-31 |
JP2006517563A (en) | 2006-07-27 |
OA13027A (en) | 2006-11-10 |
AR044496A1 (en) | 2005-09-14 |
NZ541823A (en) | 2009-01-31 |
NO20054220D0 (en) | 2005-09-12 |
TNSN05194A1 (en) | 2007-06-11 |
KR20050101215A (en) | 2005-10-20 |
AU2004212145B2 (en) | 2010-06-17 |
DE10306250A1 (en) | 2004-09-09 |
BRPI0407504A (en) | 2006-02-14 |
PE20040952A1 (en) | 2005-02-08 |
EP1597228A2 (en) | 2005-11-23 |
HRP20050710A2 (en) | 2006-07-31 |
NO20054220L (en) | 2005-10-28 |
CN1774418A (en) | 2006-05-17 |
WO2004072025A2 (en) | 2004-08-26 |
PA8595901A1 (en) | 2004-09-16 |
MA27735A1 (en) | 2006-02-01 |
RU2005128551A (en) | 2006-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL378065A1 (en) | Substituted n-arylheterocycles, method for production and use thereof as medicaments | |
IL181012A0 (en) | Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments | |
IL173204A0 (en) | Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments | |
IL191926A0 (en) | Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof | |
HK1100409A1 (en) | Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments | |
HRP20040930A2 (en) | Acyl-4-carboxyphenylurea derivatives, method for production and use thereof | |
IL180874A0 (en) | Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments | |
AU2003282094A1 (en) | Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments | |
IL176916A0 (en) | Aryl substituted heterocycles, method for production and use thereof as medicaments | |
HK1081965A1 (en) | Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same | |
PL373329A1 (en) | Heterocyclically substituted benzoylureas, method for their production and their use as medicaments | |
IL176913A0 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
IL175245A0 (en) | Thiozolidinones, production and use thereof as medicaments | |
HK1094433A1 (en) | Flocculating agent, method for the production and use thereof | |
ZA200500086B (en) | Novel carboxamide compounds having an MCH-antagonistic effect, medicaments containing said compounds, and method for the production thereof | |
HK1089768A1 (en) | Indolone-acetamide derivatives, processes for preparing them and their uses | |
AU2003257465A1 (en) | Substituted diaryl heterocycles, method for the production and use thereof as medicaments | |
IL174405A0 (en) | 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics | |
AU2003266194A8 (en) | Nanocomposite, method for production and use thereof | |
IL162669A0 (en) | Antichlinergic agents, method for producing the same and use thereof as medicaments | |
IL179170A0 (en) | Novel substituted thiophenecarboxamides, their production and their use as medicaments | |
HK1075650A1 (en) | Acyl-3-carboxyphenylurea derivatives, method for production and use thereof | |
IL162316A0 (en) | Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t | |
PL377741A1 (en) | Diarylcycloalkyl derivatives, method for their production and their use as medicaments | |
IL174438A0 (en) | Phenylacetic acid derivative, process for producing the same, and use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |